Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 9(1): 5288, 2018 12 11.
Article in English | MEDLINE | ID: mdl-30538246

ABSTRACT

The high global burden of over one million annual lethal fungal infections reflects a lack of protective vaccines, late diagnosis and inadequate chemotherapy. Here, we have generated a unique set of fully human anti-Candida monoclonal antibodies (mAbs) with diagnostic and therapeutic potential by expressing recombinant antibodies from genes cloned from the B cells of patients suffering from candidiasis. Single class switched memory B cells isolated from donors serum-positive for anti-Candida IgG were differentiated in vitro and screened against recombinant Candida albicans Hyr1 cell wall protein and whole fungal cell wall preparations. Antibody genes from Candida-reactive B cell cultures were cloned and expressed in Expi293F human embryonic kidney cells to generate a panel of human recombinant anti-Candida mAbs that demonstrate morphology-specific, high avidity binding to the cell wall. The species-specific and pan-Candida mAbs generated through this technology display favourable properties for diagnostics, strong opsono-phagocytic activity of macrophages in vitro, and protection in a murine model of disseminated candidiasis.


Subject(s)
Antibodies, Fungal/administration & dosage , Antibodies, Monoclonal/administration & dosage , B-Lymphocytes/immunology , Candida albicans/physiology , Candidiasis/immunology , Candidiasis/prevention & control , Phagocytosis , Animals , Antibodies, Fungal/genetics , Antibodies, Fungal/immunology , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/immunology , Candida , Candida albicans/drug effects , Candidiasis/microbiology , Female , Humans , Mice , Mice, Inbred BALB C
2.
Curr Opin Microbiol ; 34: 111-118, 2016 12.
Article in English | MEDLINE | ID: mdl-27689902

ABSTRACT

Candida albicans is a commensal coloniser of most people and a pathogen of the immunocompromised or patients in which barriers that prevent dissemination have been disrupted. Both the commensal and pathogenic states involve regulation and adaptation to the host microenvironment. The pathogenic potential can be downregulated to sustain commensalism or upregulated to damage host tissue and avoid and subvert immune surveillance. In either case it seems as though the cell biology of this fungus has evolved to enable the establishment of different types of relationships with the human host. Here we summarise latest advances in the analysis of mechanisms that enable C. albicans to occupy different body sites whilst avoiding being eliminated by the sentinel activities of the human immune system.


Subject(s)
Candida albicans/physiology , Host-Pathogen Interactions , Adaptation, Physiological , Animals , Candida albicans/immunology , Candida albicans/pathogenicity , Candidiasis/microbiology , Fungal Proteins/immunology , Fungal Proteins/metabolism , Humans , Immune Evasion , Mice , Symbiosis
3.
PLoS Pathog ; 12(4): e1005566, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27073846

ABSTRACT

Efficient carbon assimilation is critical for microbial growth and pathogenesis. The environmental yeast Saccharomyces cerevisiae is "Crabtree positive", displaying a rapid metabolic switch from the assimilation of alternative carbon sources to sugars. Following exposure to sugars, this switch is mediated by the transcriptional repression of genes (carbon catabolite repression) and the turnover (catabolite inactivation) of enzymes involved in the assimilation of alternative carbon sources. The pathogenic yeast Candida albicans is Crabtree negative. It has retained carbon catabolite repression mechanisms, but has undergone posttranscriptional rewiring such that gluconeogenic and glyoxylate cycle enzymes are not subject to ubiquitin-mediated catabolite inactivation. Consequently, when glucose becomes available, C. albicans can continue to assimilate alternative carbon sources alongside the glucose. We show that this metabolic flexibility promotes host colonization and virulence. The glyoxylate cycle enzyme isocitrate lyase (CaIcl1) was rendered sensitive to ubiquitin-mediated catabolite inactivation in C. albicans by addition of a ubiquitination site. This mutation, which inhibits lactate assimilation in the presence of glucose, reduces the ability of C. albicans cells to withstand macrophage killing, colonize the gastrointestinal tract and cause systemic infections in mice. Interestingly, most S. cerevisiae clinical isolates we examined (67%) have acquired the ability to assimilate lactate in the presence of glucose (i.e. they have become Crabtree negative). These S. cerevisiae strains are more resistant to macrophage killing than Crabtree positive clinical isolates. Moreover, Crabtree negative S. cerevisiae mutants that lack Gid8, a key component of the Glucose-Induced Degradation complex, are more resistant to macrophage killing and display increased virulence in immunocompromised mice. Thus, while Crabtree positivity might impart a fitness advantage for yeasts in environmental niches, the more flexible carbon assimilation strategies offered by Crabtree negativity enhance the ability of yeasts to colonize and infect the mammalian host.


Subject(s)
Candida albicans/metabolism , Candida albicans/pathogenicity , Candidiasis/metabolism , Macrophages/microbiology , Saccharomyces cerevisiae/metabolism , Virulence/physiology , Animals , Blotting, Western , Carbohydrate Metabolism , Cell Line , Female , Mice , Mice, Inbred BALB C , Ubiquitination
SELECTION OF CITATIONS
SEARCH DETAIL
...